http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019189554-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed3e9feb22b82bc70604d34288cbb954
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a82d0e644b9e99ff1ca6cba5ec194726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7af17fcd0da9e4f7637c7f634312fa7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6263772ea14990985b8a3ba50bacf84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc923a32951a730786a7f719d4c9dac3
publicationDate 2019-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2019189554-A
titleOfInvention Pharmaceutical composition with improved dissolution
abstract PROBLEM TO BE SOLVED: To provide a pharmaceutical composition having improved dissolution properties of cinacalcet hydrochloride as an active ingredient from a tablet. The active ingredient is cinacalcet hydrochloride, the excipient is (a) one or more selected from lactose hydrate, crystalline cellulose, or D-mannitol as a diluent, and (b) a disintegrant. One or more selected from crospovidone, carmellose, carmellose calcium, croscarmellose sodium, low-substituted hydroxypropylcellulose, or partially pregelatinized starch, (c) hydroxypropylcellulose as a binder, or polyvinyl alcohol polyethylene Active ingredient containing no granule / graft copolymer or binder, (d) one or more selected from lubricant magnesium stearate or talc, granulated and compression molded It is a pharmaceutical composition with improved dissolution. [Selection] Figure 1
priorityDate 2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451973021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223

Total number of triples: 43.